Treatment of renal carcinoma

The standard therapy for renal carcinoma is radical surgery. When dealing with single, under 4 cm tumors and in the case of renal tumors in single-kidney patients, the choice therapy is nephrectomy or partial nephrectomy. Response rates in metastatic renal carcinoma using the various immune therapy...

Full description

Saved in:
Bibliographic Details
Published inActas urologicas españolas Vol. 26; no. 8; pp. 541 - 545
Main Authors Arocena García-Tapia, J, López Ferrandis, J, Sánchez Zalabardo, D, Regojo Balboa, J M, Fernández Montero, J M, Rosell Costa, D, Robles García, J E, Zudaire Bergera, J J, Berián Polo, J M
Format Journal Article
LanguageSpanish
Published Spain 01.09.2002
Subjects
Combined Modality Therapy
Humans
Kidney Neoplasms - therapy
Online AccessGet full text

Cover

More Information
Summary:The standard therapy for renal carcinoma is radical surgery. When dealing with single, under 4 cm tumors and in the case of renal tumors in single-kidney patients, the choice therapy is nephrectomy or partial nephrectomy. Response rates in metastatic renal carcinoma using the various immune therapy approaches available range from 15 to 35%, responses being short-lasting.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:0210-4806